SCHEMBL25386609

SCHEMBL25386609

CC(C)(C)[Si](C)(C)OCCOCCOCCOCCOCCOCCOc1ccccc1C=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.58
HTT P42858 3/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
HPGD P15428 2/20 0.58
PTGDR2 Q9Y5Y4 1/20 0.43
MAPT P10636 2/20 0.43
DUT P33316 1/20 0.41
LMNA P02545 4/20 0.40
KDM4E B2RXH2 3/20 0.40
CYP1A2 P05177 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
CYP2D6 P10635 1/20 0.39
KMT2A Q03164 5/20 0.39
TDP1 Q9NUW8 3/20 0.39
MEN1 O00255 2/20 0.39
POLB P06746 2/20 0.39
RECQL P46063 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
RAD52 P43351 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12634929 0.96 ALDH1A1 (0.64) ALDH1A1HTTSMN1; SMN2HPGDPTGDR2
SCHEMBL31367158 0.96 ALDH1A1 (0.64) ALDH1A1HTTSMN1; SMN2HPGDPTGDR2
SCHEMBL28580980 0.89 ALDH1A1 (0.57) ALDH1A1HTTSMN1; SMN2HPGDPTGDR2
SCHEMBL28693496 0.87 ALDH1A1 (0.56) ALDH1A1HTTSMN1; SMN2HPGDPTGDR2
SCHEMBL29398599 0.84 ALDH1A1 (0.47) ALDH1A1HTTSMN1; SMN2HPGDPTGDR2
SCHEMBL22843772 0.84 ALDH1A1 (0.47) ALDH1A1HTTSMN1; SMN2HPGDPTGDR2
SCHEMBL7926214 0.82 ALDH1A1 (0.88) ALDH1A1HTTSMN1; SMN2HPGDPTGDR2
SCHEMBL7927335 0.82 ALDH1A1 (0.88) ALDH1A1HTTSMN1; SMN2HPGDPTGDR2
SCHEMBL25388321 0.81 ALDH1A1 (0.49) ALDH1A1HTTSMN1; SMN2HPGDMAPT
SCHEMBL31001969 0.78 PTGDR2 (0.41) ALDH1A1HTTSMN1; SMN2HPGDPTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4486336-A2 CB1 LIGAND CONJUGATED COMPOUNDS AND USES THEREOF Adarx Pharmaceuticals, Inc. (US) 2025-01-08 EP disclosed
WO-2023168296-A2 CB1 LIGAND CONJUGATED COMPOUNDS AND USES THEREOF ADARX PHARMACEUTICALS, INC. (US) 2023-09-07 WO disclosed